GE HealthCare Technologies Inc. (L0T.F)

75,12 +0,17 (+0,23 %) À la clôture : 03:29PM CEST

GE HealthCare Technologies Inc.

500 West Monroe Street
Chicago, IL 60661
United States
833 735 1139
https://www.gehealthcare.com

Secteur(s): Healthcare
Secteur d’activité: Health Information Services
Employés à temps plein: 51 000

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Peter J. Arduini	President, CEO & Director	3,99M	S.O.	1965
Mr. James K. Saccaro	VP & CFO	1,41M	S.O.	1973
Dr. Taha Kass-Hout M.D., M.S.	Chief Science & Technology Officer	4,29M	S.O.	1972
Mr. Frank R. Jimenez Esq.	VP, General Counsel & Corporate Secretary	1,91M	S.O.	1965
Mr. Jan Makela	President & CEO of Imaging	1,46M	2,11M	1969
Mr. George Andrew Newcomb	Controller & Chief Accounting Officer	S.O.	S.O.	1967
Mr. Jahid Khandaker	Chief Information Officer	S.O.	S.O.	S.O.
Ms. Carolynne Borders	Chief Investor Relations Officer	S.O.	S.O.	S.O.
Ms. Rana Strellis	Chief Corporate Marketing & Communications Officer	S.O.	S.O.	S.O.
Mr. Thomas J. Westrick	President & CEO of Patient Care Solutions	S.O.	S.O.	1969

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en EUR.

Description

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Gouvernance d’entreprise

L’ISS Governance QualityScore de GE HealthCare Technologies Inc. en date du 1 mai 2024 est 7. Les scores principaux sont Audit : 10; Société : 6; Droits des actionnaires : 5; Compensation : 6.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.